<div id="readability-page-1"><p>Arrowstreet Capital Limited Partnership raised its holdings in shares of  Concentrix Corporation (NASDAQ:CNXC - Free Report) by 247.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 535,843 shares of the company's stock after buying an additional 381,497 shares during the period. Arrowstreet Capital Limited Partnership owned about 0.85% of Concentrix worth $28,322,000 at the end of the most recent reporting period.</p><ul><li>Concentrix: High Debt and Struggling Margins</li></ul><p>Several other large investors have also recently modified their holdings of CNXC. Geneos Wealth Management Inc. boosted its holdings in  Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after acquiring an additional 522 shares during the period.  IFP Advisors Inc lifted its position in  Concentrix by 473.8% in the second quarter. IFP Advisors Inc now owns 700 shares of the company's stock valued at $37,000 after purchasing an additional 578 shares during the last quarter.  True Wealth Design LLC boosted its stake in shares of  Concentrix by 39.3% during the second quarter. True Wealth Design LLC now owns 1,163 shares of the company's stock valued at $61,000 after purchasing an additional 328 shares during the period.  PNC Financial Services Group Inc. boosted its stake in shares of  Concentrix by 47.3% during the first quarter. PNC Financial Services Group Inc. now owns 1,504 shares of the company's stock valued at $84,000 after purchasing an additional 483 shares during the period.  Finally, Parkside Financial Bank &amp; Trust grew its holdings in shares of  Concentrix by 23.9% in the second quarter. Parkside Financial Bank &amp; Trust now owns 1,818 shares of the company's stock worth $96,000 after purchasing an additional 351 shares during the last quarter. Hedge funds and other institutional investors own  90.34% of the company's stock. </p><h2>Concentrix Trading Up 1.8%</h2><p>NASDAQ:CNXC opened at $37.61 on Friday. The company has a 50-day moving average price of $40.83 and a 200-day moving average price of $49.45. The stock has a market cap of $2.34 billion, a price-to-earnings ratio of 7.95, a P/E/G ratio of 0.50 and a beta of 0.50. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 1.10. Concentrix Corporation has a 12 month low of $31.63 and a 12 month high of $66.00. </p><p>Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings results on Thursday, September 25th. The company reported $2.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.88 by ($0.10). Concentrix had a net margin of 3.25% and a return on equity of 16.02%. The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.46 billion. During the same quarter in the prior year, the firm earned $2.87 EPS. Concentrix's quarterly revenue was up 4.0% compared to the same quarter last year. Concentrix has set its FY 2025 guidance at 11.110-11.230 EPS and its Q4 2025 guidance at 2.850-2.960 EPS.  Equities analysts predict that  Concentrix Corporation will post 10.11 EPS for the current year. </p><h2>Concentrix Increases Dividend</h2><p>The company also recently announced a quarterly dividend, which was paid on Tuesday, November 4th. Stockholders of record on Friday, October 24th were given a $0.36 dividend. The ex-dividend date of this dividend was Friday, October 24th. This represents a $1.44 annualized dividend and a dividend yield of 3.8%. This is an increase from Concentrix's previous quarterly dividend of $0.33. Concentrix's dividend payout ratio  is currently 30.44%. </p><h2>Analysts Set New Price Targets</h2><p>A number of equities research analysts recently commented on CNXC shares. Weiss Ratings upgraded shares of Concentrix from a &#34;sell (d+)&#34; rating to a &#34;hold (c-)&#34; rating in a report on Wednesday, October 8th. Barrington Research  restated an &#34;outperform&#34; rating and issued a $62.00 price objective on shares of Concentrix in a research report on Thursday, November 20th. Canaccord Genuity Group  reiterated a &#34;buy&#34; rating and set a $80.00 target price on shares of Concentrix in a report on Tuesday, September 23rd. Wall Street Zen raised Concentrix from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, October 25th. Finally, Robert W. Baird lowered their price target on Concentrix from $75.00 to $62.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, September 29th. Three analysts have rated the stock with a Buy rating and two have issued  a Hold rating to the company's stock. According to MarketBeat.com, the stock  has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $66.25.</p><p><b>View Our Latest Report on CNXC</b></p><h2>Insider Activity at Concentrix</h2><p>In other news, CEO Christopher A. Caldwell bought 2,000 shares of the stock in a transaction dated Thursday, October 30th. The stock was bought at an average price of $42.03 per share, for a total transaction of $84,060.00. Following the purchase, the chief executive officer directly owned 286,661 shares in the company, valued at $12,048,361.83. This trade represents a 0.70% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. In the last three months, insiders purchased 4,000 shares of company stock valued at $169,410. Company insiders own  3.20% of the company's stock. </p><h2>About Concentrix</h2> (Free Report)<p>Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Concentrix</li><li>Do ETFs Pay Dividends? What You Need to Know</li><li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li><li>How to trade penny stocks: A step-by-step guide</li><li>Gates Foundation Sells MSFT Stock—Should Investors Be Worried?</li><li>Investing in Construction Stocks</li><li>MarketBeat Week in Review – 12/1 - 12/5</li></ul><p><strong>Want to see what other hedge funds are holding CNXC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q05YQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q05YQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Concentrix Right Now?</h2><p>Before you consider Concentrix, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.</p><p>While Concentrix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CNXC

<p>Arrowstreet Capital Limited Partnership increased its holdings in Concentrix Corporation by 247.2% in Q2, acquiring 381,497 shares. The firm now owns 0.85% of Concentrix, valued at $28.32 million. Concentrix's stock has been rated by analysts, with some upgrading it to 'buy' and others maintaining 'hold'. The company reported Q3 earnings of $2.78 per share, missing estimates, and announced a dividend increase to $0.36 per share.</p>

Arrowstreet Capital Limited Partnership Acquires 381,497 Shares of Concentrix Corporation $CNXC